top of page
PM_header.png

Beyond the First Intervention: Building for the Gap Between Injury Hemorrhage Control and Definitive Care

Writer: Ryan Hogan
Ryan Hogan
5 days ago
3 min read

Why Pressure Medical is focused on hemorrhage control in environments where access to higher-level care may be delayed.


The moment of injury is only the beginning of the care journey.

Pressure Medical is focused on what happens between that moment and access to definitive care—particularly in military, remote industrial, humanitarian, and other demanding environments. Our public mission centers on severe hemorrhage control in settings where reaching higher-level medical care may be difficult or delayed.


That focus shapes a fundamental question for our company:

How should hemorrhage-control technology be designed when the environment cannot be designed around the technology?

We believe the answer begins with the responder, the operating conditions, and a clear understanding of what the device must accomplish.


Navy rescue helicopter hoists a person over mountain terrain, illustrating why hemorrhage control matters when care is delayed.

Design around the setting—not just the specification

Our development focus includes smart pneumatic and junctional tourniquet technologies. These are distinct areas within our broader effort to address severe bleeding in challenging conditions.

But a product category does not fully describe the problem we want to solve.


Our design questions extend beyond whether a mechanism can perform a function under controlled conditions. We want to understand how the intended user interacts with the device, how the product fits into a response workflow, and what evidence is needed to evaluate its performance in the intended setting.


That means asking practical questions early:

• Which steps are essential, and which could create unnecessary burden?

• What information does the responder need at each stage?

• How should the design account for transport and handling?

• Which operating conditions must testing address?

• What would demonstrate meaningful value over an existing approach?


These questions are not peripheral to our strategy. We propose treating them as central product requirements.


Make complexity earn its place

Pressure Medical’s interest in smart technology is not an argument that more electronics automatically make a better medical device.

Our standard should be more demanding than that.


Any added capability should have a clear purpose. It should address a defined need, be evaluated against an explicit requirement, and justify the additional development and support it introduces.


We want to distinguish the sophistication of the engineering from the complexity experienced by the user. The former may be necessary. The latter should never be accepted without scrutiny.


That is the product philosophy we want to bring to our development work: purposeful technology, evaluated in the context of the person who must use it.

Navy personnel examine a robotic quadruped demonstration, showing the defense innovation ecosystem behind hemorrhage control technology.

Build a focused company around a broader problem

Pressure Medical’s public materials identify military and government applications as an initial commercial focus, with civilian emergency-response and industrial applications also part of the company’s stated opportunity.


Our proposed approach is to establish a defined starting point rather than pursue every potential application simultaneously.


A focused initial use case can give development a clearer set of requirements. It can also make evaluation more meaningful: a specific user, a specific setting, and a specific purpose against which the product can be assessed.


From there, expansion should follow evidence. We want to determine which capabilities transfer to additional settings and which requirements demand further work.


An opportunity measured by execution

The opportunity we want investors and partners to examine is not simply whether the mission is compelling.


It is whether Pressure Medical can translate that mission into a differentiated product, credible evidence, and a workable commercialization path.


That requires more than a persuasive description of the problem. It requires disciplined engineering, appropriate evaluation, manufacturing planning, and a clear understanding of adoption.


Our ambition is to build a company capable of doing that work well.

We are starting with a consequential part of the care journey: the period between injury and definitive care. Our next steps must turn that focus into progress others can evaluate.


Partner invitation: Pressure Medical welcomes conversations with investors and industry partners interested in advancing hemorrhage-control technology for demanding military and civilian environments.


Service member carries a casualty at night, highlighting the need for simple, reliable hemorrhage control in field conditions.

Comments


bottom of page